:: Medreich ::

Medreich has six manufacturing facilities built to comply with standards stipulated by International Regulatory bodies. The facility has been validated through successful inspections by the UK MHRA, AUSTRALIA TGA, PICS, MCC SOUTH AFRICA, CANADA HEALTH resulting in cGMP compliance / certification / accreditations by these regulatory bodies. Brief description of each of the facility is as follows:

Dedicated Betalactum Facility

This facility has the capability to manufacture all oral dosage forms of capsules, tablets, and dry powder suspensions.

Having gained technology expertise to manufacture difficult product like Co-amoxiclav and having received quality approvals, this facility offers compelling value for Medreich's customers to forge ahead in their market.

Facility is equipped with best of the equipments to formulate, fill, and package the products in diversity of formats. This Facility is equipped with Tropical Blister packing machine, Aluminium/Aluminium blisters and Sachet filling machine.

This facility is designed keeping in view of the stringent environmental conditions required for sensitive products like Amoxicillin & Clavulanic acid tablets & Dry syrups.

Facility has an independent Quality Control Laboratory duly equipped to perform all tests including microbiology. Facility also has an independent site Quality Assurance Team responsible for documentation compliance and final product release.

This facility has independent and full fledged Stability center to perform long term and Accelerated stability studies of the products manufactured.

Dedicated Cephalosporin Formulations

Medreich in its group has two dedicated Cephalosporin facilities.

Facility based in Barcelona (Spain) restricts itself only to manufacture sterile formulations. The facility caters to European and Middle East regions. The facility is self sufficient in all areas of manufacturing, procurement of materials, quality control and assurance, stability data generation, engineering, and logistics.

Second facility based in Hyderabad (India) is capable of manufacturing both oral and sterile dosage forms of cephalosporins. This facility is also self sufficient in all areas of manufacturing, procurement of materials, quality control and assurance, engineering, and logistics.

This facility has independent and full fledged Stability center to perform long term and Accelerated stability studies of the products manufactured.

Non-penicillin Oral Dosage Formulation Facilities

First facility is dedicated to Capsule formulations with three automatic filling lines supported by packaging lines to deliver products in wide variety of formats.

One of the filling lines supported by independent packaging lines is isolated to handle products which can raise contamination issues although non-penicillin’s.

Second facility is capable of handling oral dosage formulations of tablets, capsules and immediate release and sustained release pellets with aqueous and non-aqueous polymeric solutions or suspensions. The facility is equipped with very high quality equipments to handle large volumes of these formulations. Manufacturing is supported by variety of packaging lines giving the facility a flexibility to handle diverse range of packing formats including sachet filling. The facility is equipped with CCTV system with time lapse VCR to review critical operations.

Third Facility is capable manufacturing oral dosage formulations of Tablets and Liquid syrups and suspensions. The facility is equipped with very high quality equipments to handle large volumes of these formulations. Manufacturing is supported by variety of packaging lines giving the facility a flexibility to handle diverse range of packing formats including sachet filling. The facility is equipped with CCTV system with time lapse VCR to review critical operations.